BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mucosis B.V. 

L.J. Zielstraweg 1

Groningen    9713 GX  The Netherlands
Phone: 31-50-3612112 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Vaccines





 Company News
Mucosis B.V. Receives Financial Support From The Dutch Government For Its Syngem® Program 5/22/2014 9:44:29 AM
Mucosis B.V. Announces A Strategic Partnership With Changchun Bcht Biotechnology Of China And Raises Additional Capital 4/15/2014 11:02:25 AM
Mucosis B.V. Signs Research and License Option Agreement With Crucell N.V. (CRXL) 10/8/2012 10:44:12 AM
ExpreS2ion Biotechnologies, Mucosis B.V., and University of Copenhagen Receive Eurostars Grant 9/25/2012 10:31:35 AM
Mucosis B.V. Appoints Thomas Johnston to CEO 9/17/2012 8:20:38 AM
Mucosis B.V. Announces Positive Proof-Of-Concept Data for Mimopath® Platform in Humans 5/10/2012 9:08:13 AM
Mucosis B.V. Announces Publication of Preclinical Data Demonstrating Superior Protection by Mucosally Administered Mimopath®-Based Influenza Vaccines 5/3/2012 11:05:11 AM
Mucosis B.V. Announces New Scientific Advisory Board 11/15/2011 9:06:34 AM
Mucosis B.V. Appoints Thomas Johnston As Chief Business Officer 5/17/2011 10:26:36 AM
Mucosis B.V. Starts Clinical Study with its Lead Product, Flugem(TM) 3/21/2011 9:21:23 AM
12